Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference By Investing.com

Washington, May 30, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (NASDAQ:) Vanda (Nasdaq: VNDA) announced today that the company will participate in the Jefferies 2024 Global Healthcare Conference in… New York City on Thursday, June 6, 2024. A corporate presentation is scheduled 2:00 PM EST.

The company's presentation at the Jefferies 2024 Global Healthcare Conference can be accessed directly on Vanda's corporate website, www.vandapharma.com. Investors should click on the “Investors” tab and follow the link under Recent Events. Investors are advised to go to the conference site at least 15 minutes in advance to register, download and install any necessary software or presentations. The archived conference link will be available on the Vanda website for approximately 30 days.

on Vanda Pharmaceuticals a company.

Vanda is a leading global biopharmaceutical company focused on developing and commercializing innovative therapeutics to address high unmet medical needs and improve the lives of patients. For more about Vanda Pharmaceuticals CompanyPlease visit www.vandapharma.com and follow us on X @vandapharma.

Contact the company:
Kevin MoranSenior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Company
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan MooreCombined strategies
Vanda-CS@collectedstrategies.com